Stress is a common and unavoidable phenomenon in human life.1,2) Exposure to stress induces glucocorticoid release via the activation of the hypothalamo-pituitary-adrenal (HPA) axis and it modulates immune cells and further modulates cytokine production.3-5) Among these cytokines, proinflammatory interleukin (IL)-6 and tumor necrosis factor (TNF)-α are up-regulated by stress and are associated with host defense systems.6) The failure to cope with stress exacerbates both psychological and immune disorders, including anxiety, depression, cardiovascular disturbances, neuronal degeneration of the central nervous system and chronic fatigue syndromes. 7,8) Ginseng (the root of Panax ginseng C.A. MEYER, Araliaceae) has been widely used as a traditional Chinese medicine for the treatment of various maladies such as inflammation, anxiety, depression, fatigue, and stress. Its representative constituents are dammarane-type ginsenosides, which are classified into protopanaxadiols, such as ginsenosides Rb1, Rb2, Rc, and Rd, and protopanaxatriols such as ginsenosides Re and Rg1.9,10) These ginsenosides have been previously reported to show various biological activities, including anti-inflammatory, 10,11) anti-allergic, 12) anxiolytic, 13) anti-stress 14) and anti-tumor activities. 16-19) These metabolites have many pharmacological activities similar to ginseng, including anti-tumor, anti-diabetic, and anti-inflammatory effects.20-22) Therefore, to understand the pharmacological effect of ginseng, understanding the biological activities of two metabolites, 20(S)-protopanaxadiol and 20(S)-protopanaxatriol, of various ginsenosides is important. Nevertheless, the pharmacological effects of the ginsenoside metabolites have not been studied thoroughly.In our preliminary study, we also found that ginseng saponin extract showed anti-stress effect in mice. Therefore, in the present study, we investigated further the anti-stress effects of ginseng saponin metabolites, 20(S)-protopanaxadiol (PPD) and 20(S)-protopanaxatriol (PPT), in immobilized mice.
MATERIALS AND METHODSMaterials Bicuculline, buspirone, dexamethasone, flumazenil and WAY-100635 were purchased from Sigma (St. Louis, MO, U.S.A.). 20(S)-Protopanaxadiol (purity ≥98% by HPLC) and 20(S)-protopanaxatriol (purity ≥98% by HPLC) were purchased from Ambo Institute (Daejeon, Korea). Orally administered 20(S)-protopanaxadiol and 20(S)-protopanaxatriol were suspended in 0.5% carboxymethylcellulose (CMC) solution and intraperitoneally injected buspirone, flumazenil, bicuculline, and WAY-100635 were dissolved in sterilized saline.Animals Male ICR mice (age, 7 weeks-old; weight, 24-28 g) were purchased from Samtako Biokorea (Seoul, Korea) and acclimated for 1 week before use. All animals were maintained under a constant temperature (24±2°C) and humidity (60±10%) with an alternating 12 h light-dark cycle. They were fed standard laboratory chow (Samyang Co., Seoul, Korea) with tap water ad libitum. Each group consisted of 7 mice for all experiments. The mice were randomly divided